New drug-delivery stent could revolutionize women’s health
OCON Therapeutics invented a novel technology that allows for intrauterine drug delivery that could affect the wellbeing of women worldwide.
OCON Therapeutics invented a novel technology that allows for intrauterine drug delivery that could affect the wellbeing of women worldwide.
Dealing with pelvic organ prolapse less invasively with a home-use disposable pessary and two minimally invasive repair systems.
Medical aesthetics device affixes long strands to the scalp using surgical materials and a minimally invasive procedure designed for women.
ARC, Sheba Medical Center’s innovation platform, collaborates with Deloitte Consulting to develop and launch worldwide Future of Health project.
The ways that medical studies and research are growing to be more representative of women and how this shift has the potential to expand scientific development
After years of neglect, this fledgling high-tech sector is addressing the modest issue of meeting the needs of half the world’s population.
Majority of companies are focused on health, others develop solutions in fields of cosmetics, safety and sexual wellness.
Serious gynecological conditions can be detected using a new noninvasive approach to harness vast amounts of clinical and biological information.
‘We’re trying to change clinical paradigms to disrupt and improve women’s healthcare,’ says Dr. Avi Tsur of Sheba Medical Center.
Technologies include a fertility gauge, an advanced breast pump, and a gadget that can identify vitamin deficiencies or cancer in menstrual blood.